Annual Gross Profit
$177.84 M
-$52.26 M-22.71%
31 December 2023
Summary:
Vanda Pharmaceuticals annual gross profit is currently $177.84 million, with the most recent change of -$52.26 million (-22.71%) on 31 December 2023. During the last 3 years, it has fallen by -$46.96 million (-20.89%). VNDA annual gross profit is now -26.83% below its all-time high of $243.05 million, reached on 31 December 2021.VNDA Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$45.10 M
-$2.64 M-5.53%
30 September 2024
Summary:
Vanda Pharmaceuticals quarterly gross profit is currently $45.10 million, with the most recent change of -$2.64 million (-5.53%) on 30 September 2024. Over the past year, it has increased by +$9.35 million (+26.15%). VNDA quarterly gross profit is now -28.75% below its all-time high of $63.30 million, reached on 30 September 2021.VNDA Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$178.67 M
+$9.35 M+5.52%
30 September 2024
Summary:
Vanda Pharmaceuticals TTM gross profit is currently $178.67 million, with the most recent change of +$9.35 million (+5.52%) on 30 September 2024. Over the past year, it has dropped by -$15.60 million (-8.03%). VNDA TTM gross profit is now -26.49% below its all-time high of $243.05 million, reached on 31 December 2021.VNDA TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VNDA Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.7% | +26.1% | -8.0% |
| 3 y3 years | -20.9% | -28.8% | -26.3% |
| 5 y5 years | +3.0% | -14.4% | -8.6% |
VNDA Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -26.8% | at low | -28.8% | +26.1% | -26.5% | +8.8% |
| 5 y | 5 years | -26.8% | +3.0% | -28.8% | +26.1% | -26.5% | +8.8% |
| alltime | all time | -26.8% | -28.8% | >+9999.0% | -26.5% | >+9999.0% |
Vanda Pharmaceuticals Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $45.10 M(-5.5%) | $178.67 M(+5.5%) |
| June 2024 | - | $47.74 M(+8.4%) | $169.33 M(+3.2%) |
| Mar 2024 | - | $44.02 M(+5.3%) | $164.14 M(-7.7%) |
| Dec 2023 | $177.84 M(-22.7%) | $41.81 M(+16.9%) | $177.84 M(-8.5%) |
| Sept 2023 | - | $35.75 M(-16.0%) | $194.28 M(-10.7%) |
| June 2023 | - | $42.56 M(-26.3%) | $217.52 M(-6.8%) |
| Mar 2023 | - | $57.72 M(-0.9%) | $233.30 M(+1.4%) |
| Dec 2022 | $230.10 M(-5.3%) | $58.24 M(-1.3%) | $230.10 M(-1.5%) |
| Sept 2022 | - | $59.00 M(+1.1%) | $233.64 M(-1.8%) |
| June 2022 | - | $58.33 M(+7.0%) | $237.94 M(-1.2%) |
| Mar 2022 | - | $54.53 M(-11.7%) | $240.94 M(-0.9%) |
| Dec 2021 | $243.05 M(+8.1%) | $61.78 M(-2.4%) | $243.05 M(+0.2%) |
| Sept 2021 | - | $63.30 M(+3.2%) | $242.51 M(+3.8%) |
| June 2021 | - | $61.33 M(+8.3%) | $233.62 M(+2.2%) |
| Mar 2021 | - | $56.64 M(-7.5%) | $228.65 M(+1.7%) |
| Dec 2020 | $224.80 M(+10.9%) | $61.24 M(+12.6%) | $224.80 M(+3.0%) |
| Sept 2020 | - | $54.41 M(-3.5%) | $218.27 M(+0.8%) |
| June 2020 | - | $56.36 M(+6.8%) | $216.56 M(+1.7%) |
| Mar 2020 | - | $52.79 M(-3.5%) | $212.89 M(+5.0%) |
| Dec 2019 | $202.70 M(+17.4%) | $54.70 M(+3.8%) | $202.70 M(+3.8%) |
| Sept 2019 | - | $52.70 M(+0.0%) | $195.37 M(+4.6%) |
| June 2019 | - | $52.69 M(+23.7%) | $186.73 M(+6.0%) |
| Mar 2019 | - | $42.60 M(-10.1%) | $176.18 M(+2.1%) |
| Dec 2018 | $172.61 M(+17.2%) | $47.37 M(+7.5%) | $172.61 M(+4.8%) |
| Sept 2018 | - | $44.07 M(+4.6%) | $164.72 M(+4.6%) |
| June 2018 | - | $42.14 M(+8.0%) | $157.47 M(+3.0%) |
| Mar 2018 | - | $39.03 M(-1.1%) | $152.85 M(+3.8%) |
| Dec 2017 | $147.24 M | $39.48 M(+7.3%) | $147.24 M(+4.6%) |
| Sept 2017 | - | $36.81 M(-1.9%) | $140.72 M(+3.9%) |
| June 2017 | - | $37.53 M(+12.3%) | $135.40 M(+6.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $33.41 M(+1.3%) | $127.41 M(+5.0%) |
| Dec 2016 | $121.31 M(+40.3%) | $32.97 M(+4.7%) | $121.31 M(+6.4%) |
| Sept 2016 | - | $31.49 M(+6.6%) | $114.01 M(+9.3%) |
| June 2016 | - | $29.54 M(+8.2%) | $104.35 M(+8.0%) |
| Mar 2016 | - | $27.31 M(+6.3%) | $96.63 M(+11.8%) |
| Dec 2015 | $86.46 M(+78.0%) | $25.68 M(+17.6%) | $86.46 M(+14.6%) |
| Sept 2015 | - | $21.83 M(+0.1%) | $75.47 M(+11.5%) |
| June 2015 | - | $21.82 M(+27.3%) | $67.72 M(+19.7%) |
| Mar 2015 | - | $17.14 M(+16.7%) | $56.56 M(+16.5%) |
| Dec 2014 | $48.57 M(+43.4%) | $14.69 M(+4.3%) | $48.57 M(+13.8%) |
| Sept 2014 | - | $14.08 M(+32.0%) | $42.67 M(+14.4%) |
| June 2014 | - | $10.66 M(+16.6%) | $37.30 M(+6.7%) |
| Mar 2014 | - | $9.14 M(+4.1%) | $34.95 M(+35.4%) |
| Dec 2013 | $33.88 M(+3.9%) | $8.78 M(+0.8%) | $25.81 M(+51.6%) |
| Sept 2013 | - | $8.71 M(+4.7%) | $17.03 M(+104.7%) |
| June 2013 | - | $8.32 M(-0.6%) | $8.32 M(-73.4%) |
| Dec 2012 | $32.60 M(+4.2%) | - | - |
| Dec 2011 | $31.27 M(-3.3%) | $8.37 M(+5.0%) | $31.27 M(+3.7%) |
| Sept 2011 | - | $7.97 M(+7.3%) | $30.16 M(+2.5%) |
| June 2011 | - | $7.43 M(-0.9%) | $29.44 M(+2.3%) |
| Mar 2011 | - | $7.50 M(+3.3%) | $28.78 M(-11.0%) |
| Dec 2010 | $32.33 M(+1127.8%) | $7.26 M(+0.2%) | $32.33 M(+14.2%) |
| Sept 2010 | - | $7.25 M(+7.0%) | $28.31 M(+36.9%) |
| June 2010 | - | $6.77 M(-38.7%) | $20.68 M(+51.2%) |
| Mar 2010 | - | $11.05 M(+241.0%) | $13.68 M(+419.5%) |
| Dec 2009 | $2.63 M(>+9900.0%) | $3.24 M(-959.6%) | $2.63 M(-534.3%) |
| Sept 2009 | - | -$376.80 K(+64.3%) | -$606.20 K(+164.3%) |
| June 2009 | - | -$229.40 K(<-9900.0%) | -$229.40 K(<-9900.0%) |
| Mar 2009 | - | $0.00 | $0.00 |
| Dec 2008 | $0.00(0.0%) | - | - |
| Dec 2007 | $0.00 | - | - |
FAQ
- What is Vanda Pharmaceuticals annual gross profit?
- What is the all time high annual gross profit for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals annual gross profit year-on-year change?
- What is Vanda Pharmaceuticals quarterly gross profit?
- What is the all time high quarterly gross profit for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals quarterly gross profit year-on-year change?
- What is Vanda Pharmaceuticals TTM gross profit?
- What is the all time high TTM gross profit for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals TTM gross profit year-on-year change?
What is Vanda Pharmaceuticals annual gross profit?
The current annual gross profit of VNDA is $177.84 M
What is the all time high annual gross profit for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high annual gross profit is $243.05 M
What is Vanda Pharmaceuticals annual gross profit year-on-year change?
Over the past year, VNDA annual gross profit has changed by -$52.26 M (-22.71%)
What is Vanda Pharmaceuticals quarterly gross profit?
The current quarterly gross profit of VNDA is $45.10 M
What is the all time high quarterly gross profit for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high quarterly gross profit is $63.30 M
What is Vanda Pharmaceuticals quarterly gross profit year-on-year change?
Over the past year, VNDA quarterly gross profit has changed by +$9.35 M (+26.15%)
What is Vanda Pharmaceuticals TTM gross profit?
The current TTM gross profit of VNDA is $178.67 M
What is the all time high TTM gross profit for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high TTM gross profit is $243.05 M
What is Vanda Pharmaceuticals TTM gross profit year-on-year change?
Over the past year, VNDA TTM gross profit has changed by -$15.60 M (-8.03%)